Abstract
859P - Anti-tumor activity of the pan-FGFR inhibitor rogaratinib in patients with advanced urothelial carcinomas selected based on tumor FGFR mRNA expression levels
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have